MedPath

High-tech Acupuncture for Treatment of Chronic Fatigue Syndrome

Phase 2
Conditions
Chronic Fatigue Syndrome
Interventions
Other: moxibustion
Other: Acupuncture
Other: placebo
Registration Number
NCT02924831
Lead Sponsor
Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust
Brief Summary

1. To study the relationship between Chronic Fatigue Syndrome (CFS) and heart rate (HR) and its variability (HRV).

2. To compare the curative effects and the HR/HRV indices between applicationa of different acupoints as well as different treatments (acupuncture and moxibustion).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
210
Inclusion Criteria
  1. The patients meeting criteria of CFS;
  2. Aged from 18-65;
  3. With no skin lesions for the acupuncture area;
  4. Sign on the Informed Consent Form;
Exclusion Criteria
  1. Patients who can't accept and are afraid of acupuncture in the acupuncture group.
  2. Patients suffering from heart and cerebrovascular diseases, serious lung disease, diabetes, neurological diseases, or severe primary diseases such as those of liver, kidney and the hematopoietic system.
  3. Persons suffering from a mental disease, Alzheimer's disease or cancer.
  4. Persons who have taken qi-reinforcing Chinese herbal medicine in the week preceding the investigation.
  5. Pregnant women and nursing mothers.
  6. Persons suffering from thrombocytopenia and abnormalities of blood coagulation function.
  7. Persons with alcohol and drug abuse history.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Moxibustion groupmoxibustiondrug:moxa Moxibustion was to stimulate acupoints of Guanyuan(RN4)and the Zusanli(ST36) with burned moxa.
Zusanli(ST36)-acupuncture groupAcupuncturematerial: stainless steel needle Stimulating acupoints of Zusanli(ST36) with acupuncture.
Placebo groupplacebomaterial: stainless steel needle Needles were applied to acupoints of Guanyuan(RN4)and Zusanli(ST36),but without any manipulations and Deqi sensation.
Acupuncture groupAcupuncturematerial: stainless steel needle In acupuncture treatment, needles were applied to acupoints of Guanyuan(RN4)and Zusanli(ST36),with manipulations to get Deqi sensation.
Guanyuan(RN4)-acupuncture groupAcupuncturematerial: stainless steel needle. Stimulating acupoint of Guanyuan(RN4) with acupuncture.
Primary Outcome Measures
NameTimeMethod
Chalder's Fatigue Scale Score(CFSS)Two years

In CFSS, symptoms of fatigue are assessed by scores ranging from 0 to 3.

Secondary Outcome Measures
NameTimeMethod
Deficiency of Qi Scale Score (DQSS)Two years

In DQSS, symptoms are assessed by scores ranging from 1 to 3, which stand for 'mild' to 'serious'.

LF/HFTwo years

Ratio of LF and HF frequency band powers (ms²/Hz, %), calculated by LF and HF results.

Ultra-low frequency(ULF)Two years

Ultra-low frequency band (ms²/Hz, %),detected by portable HRV device.

Numeric Rating Scale(NRS)Two years

NRC is a 10cm scale to assess the fatigue degree ranging from 0 to 10, the score of 0 stands for 'no fatigue' and 10 for 'serious'.

36-item Short-Form Health Survey (SF-36)Two years

SF-36 consists of 36 items categorized as 8 dimensions: social functioning (2 items), role limitation-emotion (3 items), mental health (5 items), physical functioning (10 items), role limitation-physical (4 items), bodily pain (2 items), vitality (4 items), general health (5 items) and 1 question of health change in recent one year.

Low frequency(LF)Two years

Low frequency band (ms²/Hz, %), detected by portable HRV device.

High frequency (HF)Two years

High frequency band (ms²/Hz, %), detected by portable HRV device.

Very low frequencyTwo years

Very low frequency band (ms²/Hz, %),,detected by portable HRV device.

Total Power(TP)Two years

Total Power of heart rate variability(HRV) (ms²/Hz, %)), detected by portable HRV device.

Trial Locations

Locations (1)

Hubei university of TCM

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath